Faridabad: Sarvodaya Hospital announced on Thursday that it has partnered with the Oncidium Foundation, a global leader in advancing radio theranostics for cancer treatment.
This collaboration would make Sarvodaya Healthcare the first in India to offer sponsored access to advanced nuclear therapy for underprivileged cancer patients, stated the release. By leveraging Radio Theranostics, this initiative provides targeted, precise cancer treatment, improving outcomes for patients.
Radiotheranostics is a cutting-edge approach to cancer treatment that combines diagnostic imaging with targeted radiation therapy. This allows for precise identification and treatment of cancer cells, minimizing damage to healthy tissue.
Three patients—two from India and one from Bangladesh—have already benefitted, with many more expected to receive life-changing treatment in the coming months.
Amit Aggarwal, Director, Sarvodaya Healthcare said, we are committed to making cutting-edge nuclear therapy accessible to those who need it most—offering hope where it matters. Through this partnership with the Oncidium Foundation, we are not just treating cancer—we are creating access, delivering hope, and transforming lives.”
Dr. Swagat Dash, HOD & Senior Consultant – Nuclear Medicine, Sarvodaya Hospital, Faridabad, stated, “I am deeply honoured to serve as the first Oncidium Foundation Ambassador in India. This partnership with Sarvodaya Healthcare is a crucial step towards ensuring that more underprivileged patients have access to the life-saving benefits of Radiotheranostics.”
